|Application ||IHC-P, IHC-Fr, Flo|
|Dilution||Flo (1:50-1:100), IHC-P (10 µg/ml),|
|Other Names||Complement receptor type 1, C3b/C4b receptor, CD35, CR1, C3BR|
|Target/Specificity||Is a single chain cell surface glycoprotein which exists in four allotypic forms (A, B, C, D) of 190kD, 220kD, 160kD and 250kD respectively. The molecule is expressed by granulocytes, monocytes, B cells and some T cells. Functionally CD35 acts as a r ...|
|Reconstitution & Storage||+4°C or -20°C, Avoid repeated freezing and thawing.|
|Precautions||CR1 / CD35 Antibody (clone E11, Azide-free) is for research use only and not for use in diagnostic or therapeutic procedures.|
|Function||Mediates cellular binding of particles and immune complexes that have activated complement.|
|Cellular Location||Membrane; Single-pass type I membrane protein|
|Tissue Location||Present on erythrocytes, leukocytes, glomerular podocytes, and splenic follicular dendritic cells|
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abgent to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
firstname.lastname@example.org, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Mediates cellular binding of particles and immune complexes that have activated complement.
Klickstein L.B.,et al.J. Exp. Med. 168:1699-1717(1988).
Vik D.P.,et al.J. Immunol. 151:6214-6224(1993).
Gregory S.G.,et al.Nature 441:315-321(2006).
Wong W.W.,et al.J. Exp. Med. 169:847-863(1989).
Hourcade D.,et al.J. Exp. Med. 168:1255-1270(1988).
If you have used an Abgent product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at email@example.com.